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Summary 29 
Whey proteins mixed with salal fruits extract (0% - 20% w/w) were hydrolyzed with 30 
Pronase E from Streptomyces griseus for a period of 8 h. The ACE inhibitory activity 31 
of the hydrolysates was highest (IC50: 0.087 mg/mL) for samples fortified with the 32 
highest extract concentration (20%). Peptides (>7 amino acids) with documented ACE 33 
inhibitory activity (DAQSAPLRVY, ALPMHIR, DKVGINY, LHLPLPL, YPFPGPI, 34 
YPFPGPIPN, VYPFPGPIPN) were identified bv LC-MS/MS data analysis using a 35 
database search approach. Fluorescence spectra of the whey proteins mixed with salal 36 
fruits extract indicates fluorescence quenching for α-lactalbumin. SDS-PAGE analysis 37 
suggests that α-lactalbumin is less susceptible to proteolysis when the extract is 38 
included in the formula. Data indicate that α-lactalbumin may be interacting with 39 
phenolic compounds naturally present in salal fruits. These interactions and the 40 
formation of complexes between a-Lac and phenolic compounds may affect the 41 
hydrolysis pattern of whey protein and the release of peptides with ACE-inhibitory 42 
activity. 43 
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 46 
Introduction 47 
Whey is a secondary product of the dairy industry, which is typically generated during 48 
cheese manufacturing. Considering that millions of tons of whey are produced 49 
worldwide and that this product retains the soluble fraction of the milk proteins, 50 
valorization strategies such as membrane separation technologies have been exploited 51 
for the development of valuable protein ingredients from whey (Brans et al., 2004). 52 
Whey-derived protein products differ in protein content and can possess variable 53 
nutritional and functional properties, which is highly desirable by the food and drink 54 
industry for product formulation (Prazeres et al.,2012).  55 
In recent years, there is an increasing demand for the development of new or 56 
reformulation of existing food and drink products with enhanced nutritional properties. 57 
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In addition, there is a growing interest for inclusion in foods of natural products with 58 
bioactive ingredients which may beneficially affect one or multiple physiological 59 
processes upon consumption. There are numerous examples of composite foods which 60 
contain milk proteins and fruits in various forms, among other ingredients. A typical 61 
example of such products in terms of composition are mixed beverages, which are 62 
gaining popularity in the food market (Zulueta et al., 2007). Another example is the 63 
addition of fruits or fruits extracts in dairy products such as yogurts (Trigueros et al., 64 
2011).  65 
The incorporation of fruits in food formulations containing whey proteins is very 66 
likely to affect the nutritional and health-related properties of the product. Whey 67 
proteins have demonstrated ACE inhibitory activity upon hydrolysis by diverse 68 
commercial enzymes (Brandelli et al., 2015). ACE inhibition is important in blood 69 
pressure regulation and synthetic inhibitors are currently used for treatment of arterial 70 
hypertension (Erdmann et al., 2008). Thus, peptides released from β-lactoglobulin and 71 
α-lactalbumin in composite foods may exert their physiological activity against ACE if 72 
they can withstand gastric digestion, reach the small intestine and be made bioavailable 73 
in the systemic circulation. On the other hand, previous in vitro research has indicated 74 
that whey proteins can bind to and interact with dietary polyphenols and binding 75 
affinities are influenced by the structure of the later (Xiao et al., 2011). These 76 
interactions can be of hydrophobic nature, hydrogen bonding or electrostatic and may 77 
result in protein structural rearrangement and partial protein unfolding (Zhang et al., 78 
2014). Interactions between milk proteins and phenolic compounds have also been 79 
confirmed in real food systems with a high degree of structural complexity and may 80 
affect protein bioavailability (Oliveira et al., 2015).  81 
Previous research suggests that yogurt reformulation with salal fruits extract may 82 
induce changes in protein conformation and can affect the susceptibility to enzymatic 83 
hydrolysis by lactic acid bacteria resulting in the release of peptides with altered 84 
functionality (He et al., 2018). To further investigate the effect on peptide functionality 85 
due to possible interactions of whey proteins with phenolics from salal fruits, an 86 
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enzymatically-controlled hydrolysis process with a protease from Streptomyces griseus 87 
was employed. The objective of this study was to determine the ACE-inhibitory activity 88 
of hydrolysates released from the controlled hydrolysis of whey protein isolate 89 
supplemented with salal fruits using a protease from Streptomyces griseus and interpret 90 
the findings based on modifications of protein structure and interactions with phenolics. 91 
Mass spectrometry data combined with a database search approach was adopted to 92 
compare hydrolysis patterns between treatments and identify literature-cited bioactive 93 
peptides. The aim of this work is to better understand the enzymatic hydrolysis of whey 94 
proteins in mixtures with plant phenolic compounds and identify optimum conditions 95 
for the release of ACE-inhibitory peptides from an edible source. 96 
 97 
Materials and methods 98 
Materials 99 
Pure whey isolateTM 90 (food grade) was purchased from Bulk Powders (Colchester, 100 
UK). Dried and powdered salal fruits were supplied by James Hutton Institute (Dundee, 101 
Scotland). Protease from Streptomyces griseus (Pronase E), L-serine, O-102 
Phthaldialdehyde (OPA), Angiotensin converting enzyme (ACE) from rabbit lung, 103 
Hippuric acid, N-Hippuryl-His-Leu hydrate (HHL) and trifluoroacetic acid were 104 
purchased from Sigma-Aldrich (Dorset, UK). Amicon® Ultra-0.5 (3kDa) centrifugal 105 
filter units were purchased from Sigma-Aldrich (Dorset, UK). Muslin squares (45 cm) 106 
were purchased from Lakeland (Aberdeen, UK). Precast gels and all reagents used for 107 
protein electrophoresis were purchased from Bio-Rad Laboratories Ltd (Hertfordshire, 108 
UK). α-lactalbumin (α-Lac) and β-lactogobulin (β-Lg) were purchased from Shanghai 109 
YuanYe Biotechnology Co. Ltd (Shanghai, China). All other reagents used were of 110 
analytical grade. 111 
 112 
Preparation of whey protein fortified with salal berry (SB) and enzymatic hydrolysis 113 
14 gr of purified water was added to 1 g of dried fruit for preparing each aqueous extract. 114 
The extracts were mixed for 1 h on a Stuart SRT6 tube roller (Cole-Palmer, 115 
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Staffordshire, UK) at room temperature and then centrifuged at 2290 x g for 10 min 116 
using an EppendorfTM 5702R (Fisher Scientific, Loughborough, UK). The supernatant 117 
was collected and filtered with muslin squares to remove any residues. The extraction 118 
process was repeated 2 times and liquid extracts were combined and stored at -20 °C.  119 
Pure whey isolateTM 90 (6% w/w) was hydrated overnight at 4 °C and aqueous berry 120 
extracts were added (5%, 10% and 20%, w/w) and allowed to mix on a tube roller for 121 
4 h at room temperature before samples were stored at -20 °C until further analyses. 122 
The recipes were adjusted with water for samples with lower extract concentrations. 123 
Whey protein-SB mixtures were diluted for 10 times using 0.1 mol/L phosphate buffer 124 
(pH 7.4). 20 ml of diluted samples were mixed with 200 µl of 5 mg/mL Pronase E and 125 
then incubated at 37 °C for 8 h. Aliquots of the hydrolysate were collected before 126 
enzyme addition and every 1 h, and reactions were stopped by heating the samples in a 127 
water bath at boiling temperature for 10 min. Hydrolysates were stored at -20 °C for 128 
further analyses. 129 
 130 
Determination of particle size  131 
Particle size was determined using static multiple light scattering with a Turbiscan 2000 132 
apparatus (Formulaction, Ramonville St. Agne, France). The light source scanned the 133 
samples (whey protein-SB mixtures) at 5-min interval from top to bottom and measured 134 
the percentage of light transmitted during a 1 h period at 25 °C. The transmission level 135 
of the continuous phase (water) was set at 89%, volume fraction at 6% and the refractive 136 
indices for particle size calculation were 1.54 for the dispersed phase and 1.33 for the 137 
continuous phase (Purwanti et al., 2012).  138 
 139 
Degree of hydrolysis 140 
The OPA method as described by Rao et al. (2018) was used to determine the degree 141 
of hydrolysis (DH) of the samples incubated with Pronase E for different incubation 142 
periods. The reaction was initiated by adding 400 µL of hydrolysate into 3 mL of OPA 143 
reagent. After vortexing, the samples were incubated for 2 min at room temperature and 144 
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the absorbance was measured at 340 nm using a spectrophotometer (SpectraMax 190, 145 
Molecular Devices Limited, Berkshire, UK). L-serine (0.9516 meq/L) was used as 146 
positive control and distilled water as negative control. 147 
 148 
ACE-inhibitory activity of whey protein hydrolysate 149 
The ACE-inhibitory activity of the hydrolysates (0-20% SB) was determined using a 150 
Reversed Phase High-Performance Liquid Chromatography (RP-HPLC) method as 151 
described by He et al. (2012) with slight modifications. HHL was dissolved in 0.1 mol/L 152 
Na-borate buffer (pH 8.3) containing 1.55 mmol/L NaCl. ACE was dissolved in the 153 
same buffer at a concentration of 0.2 U/mL. 10 µL of hydrolysate were mixed with 5 154 
µL of ACE solution, and then incubated at 37°C for 5 min. 50 mL of HHL solution were 155 
added and the solution was incubated for 1 h. The reaction was stopped by adding 250 156 
mL of 0.1% TFA. The amount of hippuric acid (HA) yielded by ACE catalysis was 157 
measured by RP-HPLC with a Phenomenex Kinetex C18 column (250mm × 4.6mm, 5 158 
µm). The activity of ACE was measured by the production of hippuric acid. The mobile 159 
phase was 50% methanol (V/V) at a flow rate of 0.8 mL/min. The effluent was 160 
monitored at 228 nm. ACE-inhibitory activity was calculated as follows: 161 
 162 
ACE inhibitory activity (%) =
𝐵 − 𝐴
𝐵 − 𝐶
 × 100% 163 
 164 
where A is the content of HA generated in the presence of hydrolysate, B is the content 165 
of HA generated without hydrolysate, and C is the content of HA generated without 166 
ACE. The IC50 was defined as the concentration of inhibitor required for 50% inhibition 167 
of ACE.  168 
 169 
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) 170 
SDS-PAGE was carried out according to the method described by He et al. (2018) using 171 
a Mini-Protean○R 3 electrophoresis cell unit (Bio-Rad, Hertfordshire, UK). Hydrolysates 172 
(0% and 20% SB) incubated with Pronase E for different incubation periods (0 – 8 h) 173 
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were analyzed on a 4-20% Mini-Protean ○R   TGXTM precast gel under reducing 174 
conditions (2-mercaptoethanol). Electrophoretic migration was performed at 200 V 175 
(constant) for 30 min. The resulting gels were stained, de-stained and scanned 176 
according to the detailed method referenced above. Stained bands were compared 177 
against standards of known molecular weight.  178 
 179 
Fluorescence spectroscopy 180 
The interactions between whey proteins (α-Lac and β-Lg) and SB were analyzed with 181 
a Hitachi F-4500 spectrofluorometer (Hitachi High-Technologies Corp., Tokyo, Japan) 182 
according to the method by Zhang et al. (2014). Protein fluorescence was measured at 183 
constant protein concentration (α-Lac or β-Lg) of 0.5 mg/mL and SB extract (2.2) was 184 
added at different concentrations (0-20%, w/w). The emission spectra were obtained by 185 
excitation at 280 nm and 295 nm and collecting the spectra in the range 300 and 500 186 
nm. Slit widths were set at 1 nm for excitation and emission. The resulted spectra were 187 
expressed as arbitrary units.  188 
 189 
Peptide identification using Proteomics-Q Exactive LC-MS 190 
Hydrolysates were prepared for peptide identification as described by Kunda et al. 191 
(2012) with the addition of a size separation step to select peptides smaller than 3 kDa . 192 
Briefly, 0.2 mL of samples (0% and 20% SB) hydrolyzed with Pronase E for 4 h and 8 193 
h were centrifuged at 12000 ×g for 30 min in Amicon○R  Ultra-0.5 centrifugal filter 194 
device (3 kDa), and the filtrate (<3 kDa) was collected. Solid-phase extraction (SPE) 195 
with Bond Elut Plexa (Agilent, UK) polymeric SPE cartridges was used to elute 196 
peptides before LC-MS experiments. Peptide samples were analyzed using the method 197 
described in detail by He et al. (2018) by an UltiMate 3000 RSLCnano liquid 198 
chromatography system (Thermo Scientific Dionex, MA, USA) configured for pre-199 
concentration onto a nano column fitted to an EASY-Spray ion source (Thermo 200 
Scientific) and connected to a Q Exactive Plus quadrupole-Orbitrap hybrid mass 201 
spectrometer (Thermo Scientific). Peptides were identified from database searches 202 
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against the Bos taurus sequences, using the Mascot search engine and no enzyme 203 
specificity, as described by He et al. (2018). Theoretical peptide sequences having 204 
Mascot ion scores of at least 13 were accepted as valid identifications of bioactive 205 
peptides. The bovine database (https://www.uniprot.org/) was used for protein 206 
identification. The whey peptides thus identified were screened for bioactivity using 207 
the Milk Bioactive Peptide Database (MBPDB, http://mbpdb.nws.oregonstate.edu/) 208 
(Nielsen et al., 2017). 209 
 210 
Results and discussion 211 
Effects of SB fortification on whey protein structure  212 
Light scattering techniques have been previously used to study the complexation of 213 
proteins with polyphenols (Lin et al., 2004; Poncet-Legrand et al., 2006). The size of 214 
the particles detected in whey protein-SB extract mixtures are presented in Figure 1. 215 
Data show an incremental effect in particle size with increasing SB extract 216 
concentration. This observed effect becomes significant (P<0.05) for 10% and 20% SB 217 
compared to control (0% SB) and 5% SB respectively. At 20% SB extract concentration 218 
the average size of the particles is 1.7 times larger compared to the control sample (47.5 219 
nm vs 25.5 nm respectively). Similar results by previously published studies indicate 220 
an increase in the size of complexes formed between whey proteins and plant 221 
polyphenols, with increasing content of the later (von Staszewski et al., 2011). The 222 
reactivity of whey proteins with plant phenols has been documented in both model 223 
(single phenolic compounds) and mixed (plant extracts) systems (Rawell et al., 2001).  224 
To further investigate the reactivity of whey proteins with phenolic compounds 225 
present in SB extract, fluorescence spectra were obtained for α-lactalbumin and β-226 
lactoglobulin. Whey proteins contain residues (Trp, Tyr and Phe) which can emit 227 
intrinsic fluorescence after absorbing ultraviolet light and thus this methodology is 228 
appropriate for investigating the structural transition and binding properties of whey 229 
proteins in solution (Yuan et al., 2007). Figure 2 presents the fluorescence spectra of α-230 
lactalbumin (A and C) and β-lactoglobulin (B and D). The fluorescence intensity of α-231 
9 
 
lactalbumin is quenched with increasing SB extract concentration and a significant shift 232 
in λmax is also observed. This effect, known as fluorescence quenching, is attributed to 233 
interactions between α-lactalbumin and phenolic compounds (Zhang et al., 2014). 234 
Similar findings have been reported for whey proteins and natural polyphenols from 235 
grapes (Liang et al., 2008; Stănciuc et al., 2017). According to the literature, protein-236 
polyphenol interactions are mediated primarily through hydrophobic bonds between 237 
amino acid side chains and polyphenol aromatic rings and less commonly with 238 
hydrogen bonds and is therefore regarded as a surface phenomenon (Charlton et al., 239 
2002). Interestingly, the fluorescence spectra of β-lactoglobulin were unaffected by the 240 
addition of SB extract and thus there is no indication of molecular interaction of the 241 
most abundant whey protein with phenolic compounds. This finding contradicts 242 
previous research which suggests that complex formation between whey protein and 243 
strawberry-derived phenolic compounds in yogurt are mainly attributed to β-244 
lactoglobulin (Oliveira et al., 2015). This suggests that the formation of complexes is 245 
determined by the nature of the polyphenol as well as the presence of other components 246 
in the food system (Prigent et al., 2003). Salal fruits are a good source of anthocyanins 247 
and may also contain considerable amounts of flavonols, hydroxycinnamic acid and 248 
proanthocyanidin components (McDougall et al., 2016).  249 
The analysis of the electrophoretic mobility of whey protein hydrolysates revealed 250 
that α-lactalbumin is not fully digested after the 8 h incubation period (Fig. 3). On the 251 
contrary, β-lactoglobulin is not visually detectable after 1 h of incubation with the 252 
protease. Furthermore, the intensity of the bands corresponding to α-lactalbumin in the 253 
presence of SB (20%) extract suggests that the protein is even less digested in the later 254 
case. Thus, the formation of complexes between α-lactalbumin and phenolic 255 
compounds from SB extract may induce protein conformational changes which affect 256 
the susceptibility of the protein to proteolytic cleavage. Interestingly, for both non-257 
hydrolyzed samples (A and B), fade but distinctive bands are visible in the range of 25-258 
35 kDa, which are likely to be attributed to caseins. This suggests that caseins are not 259 
fully removed from the isolate during the purification process. 260 
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 261 
Peptide identification and ACE-inhibitory activity of hydrolysates fortified with 262 
SB 263 
The use of proteolytic enzymes for the release of peptides with ACE inhibitory activity 264 
from whey proteins has been previously documented (Otte et al., 2007; Tavares et al., 265 
2011; Morais et al., 2013; Jeewanthi et al., 2017). The whey-derived peptides typically 266 
contain 2-12 amino acids residues and the C-terminal position is occupied by 267 
hydrophobic/aromatic amino acids (Lopez-Fandino et al., 2006; Corrêa et al., 2014). 268 
The ACE inhibitory activity of the whey hydrolysates after 8 h incubation is presented 269 
in Fig. 4. The corresponding IC50 (mg/mL) values follow the order: 20% (0.087) <5% 270 
(0.109) < 10% (0.117) <0% (0.118) and indicate that fortification with salal fruits at 20% 271 
increases ACE inhibitory activity. This effect could be due to the extent of hydrolysis 272 
of whey proteins by Pronase E, which was significantly higher (P<0.05) for 20% SB 273 
compared to the control (0%) after 4 h of incubation and until the end of the incubation 274 
period (Fig. 5). This data suggest that whey protein hydrolysis increases with incubation 275 
time for all samples and the degree of hydrolysis is also affected by the addition of SB 276 
extract at high concentration (20%). Previous studies reported a positive correlation 277 
between the increase in hydrolysis time or the decreasing size of peptides and ACE 278 
inhibitory activity (Hernández-Ledesma et al., 2002; Chobert et al., 2005). Peptides of 279 
low molecular mass (<3 kDa) are considered potent inhibitors of ACE and may also 280 
play a physiological antihypertensive role in vivo (Mullaly et al., 1997). Thus, the 281 
beneficial effect against ACE inhibition observed in this study may be attributed to the 282 
extensive hydrolysis of whey proteins at high SB concentration (20%). 283 
 A peptidomic database-search approach was employed to investigate if peptides of 284 
known bioactivity are present in the hydrolysates (Giacometti and Buretić-Tomljanović, 285 
2017). The list of bioactive peptides released from whey hydrolysates (0% and 20%) 286 
after 8 h incubation is presented in Table 1. According to the literature, the peptides 287 
identified have predominantly ACE and DPP-IV inhibitory activity. Many of these 288 
peptides, which are mainly derived from β-lactoglobulin, contain hydrophobic amino 289 
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acids (i.e. Tre, Tyr, Phe, Pro) at the C-terminal position and branched-chain amino acids 290 
(i.e Ile, Val) at the N-terminal position (Wu and Ding, 2002; Yust et al., 2003). Bioactive 291 
peptides from β-casein were also identified, which confirms the presence of casein 292 
fractions in the whey protein isolate mixture. These are mainly associated with ACE-293 
inhibitory activity and may contribute to the observed effects in this study. Numerous 294 
peptides with no documented bioactivity were identified exclusively in the whey 295 
sample with 20% SB extract (supplementary material). Overall the number of peptides 296 
identified from the sample with SB extract (20%) and particularly deriving from β-297 
lactoglobulin after 4 h of incubation (data not shown) was higher compared to the 298 
control (0%). This finding agrees with the data from the degree of hydrolysis and 299 
indicate that the addition of SB extract may facilitate the hydrolysis of whey proteins 300 
by Pronase E. A limitation of the methodology adopted for peptide identification lies in 301 
the fact that any peptides with a mass lower than 750 Da would not have been detected. 302 
Hence, although it is very likely that peptides of 2-6 amino acids in length are generated 303 
in high numbers, peptide sequences of 7 residues or above are only listed. Further work 304 
is needed to investigate the bioactivity of the identified peptides from this study.  305 
 306 
Conclusions 307 
Whey proteins are commonly mixed with plant phenols in various food formulations. 308 
The addition of plant phenolics in the diet is likely to have an impact on health-309 
promoting properties of composite foods beyond the well documented antioxidant 310 
effects. Particle size analysis of the incubated samples indicates extensive interactions 311 
between whey proteins and phenolic compounds naturally present in salal fruits. 312 
Fluorescence data suggests that α-lactalbumin is primarily involved in interactions with 313 
phenols from salal fruits. Hydrolysates from whey protein incubated with salal fruits 314 
extracts exhibited higher ACE inhibitory activity compared to whey protein 315 
hydrolysates. Peptides of documented bioactivity (ACE and DPP-IV inhibition) were 316 
identified by analyzing the MS/MS data using a protein sequence database approach. 317 
The susceptibility to enzymatic hydrolysis may be altered because of protein 318 
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rearrangements, which are induced by interactions of α-lactalbumin with phenolic 319 
compounds. This may facilitate the release of peptides with ACE-inhibitory activity 320 
under controlled hydrolysis conditions. Casein-derived peptides with ACE-inhibitory 321 
activity were also identified in the hydrolysates, which suggests that whey protein 322 
isolates may contain casein fractions. Composite foods containing milk proteins with 323 
plant dietary phenols can be sources of bioactive components with potential therapeutic 324 
applications for the prevention and management of diet-related noncommunicable 325 
diseases.  326 
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